SORRENTO THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 15506000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2020-12-31) |
| Status | current |
| Entity | SORRENTO THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:26:07.310866+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/94124c2c-af0a-4c51-8ea0-d8712129e744
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-006983 · Open the official SEC filing →Retrieved: 2026-08-19T08:26:07.310866+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000850261/accounts-receivable/2020-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/94124c2c-af0a-4c51-8ea0-d8712129e744
History
- no predecessors — first report